Ogsiveo 150 MG Tablet 7-Day 14 Count Pack
- RxCUI
- 2680370
- RxNorm name
- Ogsiveo 150 MG Tablet 7-Day 14 Count Pack
- Display name
- Ogsiveo 150 MG Tablet 7-Day 14 Count Pack
- Full name
- Ogsiveo 150 MG Tablet 7-Day 14 Count Pack
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:27
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| OGSIVEO | NIROGACESTAT | SpringWorks Therapeutics, Inc. | f172e6ff-3190-41b0-b95a-58a7ef9e9e1e | 2026-03-26 | Warnings, Adverse reactions | 2680370 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| f172e6ff-3190-41b0-b95a-58a7ef9e9e1e | Ogsiveo 150 MG Tablet 7-Day 14 Count Pack | PSN | 14 | These highlights do not include all the information needed to use OGSIVEO safely and effectively. See full prescribing information for OGSIVEO. OGSIVEO ® (nirogacestat) tablets, for oral use Initial U.S. Approval: 2023 | 20260326 |
| f172e6ff-3190-41b0-b95a-58a7ef9e9e1e | Ogsiveo 150 MG Tablet 7-Day 14 Count Pack | SY | 14 | These highlights do not include all the information needed to use OGSIVEO safely and effectively. See full prescribing information for OGSIVEO. OGSIVEO ® (nirogacestat) tablets, for oral use Initial U.S. Approval: 2023 | 20260326 |
| f172e6ff-3190-41b0-b95a-58a7ef9e9e1e | {14 (nirogacestat 150 MG Oral Tablet [Ogsiveo]) } Pack [Ogsiveo 150 MG 7-Day] | BPCK | 14 | These highlights do not include all the information needed to use OGSIVEO safely and effectively. See full prescribing information for OGSIVEO. OGSIVEO ® (nirogacestat) tablets, for oral use Initial U.S. Approval: 2023 | 20260326 |